The global therapeutic bed market size is expected to reach USD 6.5 billion by 2030, registering a CAGR of 5.09% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic disorders, such as cancer, heart disorders, neurological disorders, kidney disorders, and others, and the growing geriatric population are the key driving factors for the market. According to the WHO, in 2020, the chronic illness prevalence increased by 57%, which is anticipated to spur market growth in the near future. The COVID-19 outbreak in 2020 increased the demand for therapeutic beds significantly.
The pandemic has boosted the demand for emergency supplies, medicines, and medical equipment, such as ventilators, and hospital beds, as a result of increased hospital admissions. In addition, firms are also adopting several strategies, such as collaborations and new product launches, to help healthcare workers. For instance, in August 2020, Project C.U.R.E. received 22,500 Emergency Relief Bed (ERB) sets from Stryker. A mattress, IV pole, and bed frame were included in the ERB kits. As a result, the market is likely to grow substantially in the near future.
Furthermore, pressure injuries are a common and significant economic challenge for healthcare systems globally, costing the U.S. healthcare system more than USD 23.50 billion each year. Various manufacturers began offering solutions, such as special beds, therapeutic mattresses, and repositioning solutions, to reduce the burden of pressure injuries. Moreover, after the onset of the COVID-19 pandemic, there has been extensive demand for pressure relief beds & mattresses in hospitals and rehabilitation centers. These factors are expected to boost the market growth over the forecast period.
Request a free sample copy or view report summary: Therapeutic Bed Market Report
The clinical beds product segment held the largest share of around 48.75% in 2022.
High ICU admission rates owing to a rise in the number of accidents, growth in the geriatric population, and outbreaks of life-threatening infectious diseases are driving the segment.
The acute care beds application segment held the largest share of around 43.0% in 2022.
This growth was attributed to multifunctional applications, such as managing labor (maternity), providing treatment to the injury, reducing the severity of mental illness, and protecting against exacerbation or complications.
The market in Europe held a substantial revenue share of 35.7% in 2022 owing to a rise in the number of surgical procedures, high geriatric population, and favorable reimbursement policies in the region.
Grand View Research has segmented the global therapeutic bed market on the basis of product, application, end-use, and region:
Therapeutic Bed Product Outlook (Revenue, USD Million, 2018 - 2030)
Clinical Beds
Regular Beds
ICU Beds
Pediatric Beds
Birthing Beds
Bariatric Beds
Low Air Loss Beds
Others
Household Beds
Accessories
Therapeutic Bed Application Outlook (Revenue, USD Million, 2018 - 2030)
Acute Care Beds
Critical Care Beds
Long-term Beds
Therapeutic Bed End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital & Clinics
Reproductive Care Centers
Others
Therapeutic Bed Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Therapeutic Bed Market
Hill Rom, Inc. (Baxter)
Stryker Corporation
Invacare Corporation
Medline Industries
Medical Depot Inc.
GF Health Products, Inc.
Centromed Ltd.
Arjo
Amico Group of Companies
Bakare Beds Ltd.
Gendron, Inc.
Hard Manufacturing Company Inc.
"The quality of research they have done for us has been excellent..."